FIELD: chemistry.
SUBSTANCE: invention refers to sulphated oligosaccharides of the general formula X-[Y]n-Z-UR1, where X, Y and Z each are the same hexose monosaccharide fragment selected out of group including glucose, mannose, altrose, allose, talose, galactose, idose and gulose, adjoining monosaccharide fragments are bound in 1→2, 1→3, 1→4, and/or 1→6 pattern by glycoside bonds, and each carbon atom not binding X, Y and Z groups is bound by single bond with UR group, with exception for carbon atom in 1 position of Z monosaccharide, to which UR1 group is bound by single bond; where n is an integer within 0 to 6; U is O atom or NH; each R is independently C2-C6-alkenyl, benzyl, SO3M or H, where M is any pharmaceutically acceptable cation of alkali metal or organic amine, or R form N3 together with U; R1 is C1-C12alkyl, benzyl, PEG monomethyl ether or its derivative, C1-C12alkylazide, , or , in the form of ester, free acid, free base or hydrate. Also invention refers to pharmaceutical or veterinary composition based on claimed compounds, for disorder prevention or treatment for mammals in case of proliferate retinopathy, solid tumour and/or metastasis result, coagulation/thrombosis and/or virus infection of organism. Additionally invention refers to application of claimed compounds in medicine production for disorder prevention or treatment for mammals in case of proliferate retinopathy, solid tumour and/or metastasis result, coagulation/thrombosis and/or virus infection of organism.
EFFECT: increased efficiency of compound application in medicine.
11 cl, 3 tbl, 1 dwg, 16 ex
Title | Year | Author | Number |
---|---|---|---|
5,6-BIS-(1',2':3',4'-DI-O-ISOPROPYLIDENE-α-D-GALACTOPYRANOSO-6'-YL)-1,3-DIIMINOISOINDOLINE | 2009 |
|
RU2409586C1 |
4,5-BIS-(1',2':3',4'-DI-O-ISOPROPYLIDENE-α-D-GALACTOPYRANOSO-6'-YL)PHTHALONITRILE | 2009 |
|
RU2409585C1 |
SYNTHESIS OF EPOTHILIONES, INTERMEDIATE PRODUCTS THEREOF, ANALOGUES AND USE THEREOF | 2003 |
|
RU2462463C2 |
SYNTHESIS OF EPOTILONS, THEIR INTERMEDIATE SUBSTANCES, ANALOGUES AND THEIR USING | 2003 |
|
RU2311415C2 |
FLUOROTAXOLS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT | 1993 |
|
RU2131874C1 |
VITAMIN D PRECURSORS, METHOD FOR PREPARATION THEREOF, AND INTERMEDIATES | 2000 |
|
RU2247710C2 |
METHOD OF SYNTHESIS OF FUCOSYLATED CARBOHYDRATE, METHOD OF SYNTHESIS OF FUCOSYLATED SIALYLATED CARBOHYDRATE MOLECULE, REACTION SYSTEM IN VITRO | 1992 |
|
RU2125092C1 |
METHODS FOR SYNTHESIS OF APLIDINE AND NOVEL ANTI-TUMOR DERIVATIVES, METHODS FOR THEIR INDUSTRIAL PREPARING AND USING | 2001 |
|
RU2299887C2 |
GLUCOSE-RESPONSIVE INSULIN CONJUGATES | 2014 |
|
RU2676307C2 |
FUNCTIONALISED BETA 1, 6 GLUCOSAMINE-DISACCHARIDES AND METHOD FOR PREPARING THEM | 2007 |
|
RU2481352C2 |
Authors
Dates
2010-06-20—Published
2005-03-04—Filed